312 related articles for article (PubMed ID: 25528767)
21. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
22. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
23. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
[TBL] [Abstract][Full Text] [Related]
24. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
25. MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.
Wang X; Huang Z; Wu Q; Prager BC; Mack SC; Yang K; Kim LJY; Gimple RC; Shi Y; Lai S; Xie Q; Miller TE; Hubert CG; Song A; Dong Z; Zhou W; Fang X; Zhu Z; Mahadev V; Bao S; Rich JN
Cancer Res; 2017 Sep; 77(18):4947-4960. PubMed ID: 28729418
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
27. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
28. C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas.
Di Pascale F; Nama S; Muhuri M; Quah S; Ismail HM; Chan XHD; Sundaram GM; Ramalingam R; Burke B; Sampath P
Nucleic Acids Res; 2018 Jan; 46(1):336-349. PubMed ID: 29136251
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
Dang CV
Cold Spring Harb Symp Quant Biol; 2011; 76():369-74. PubMed ID: 21960526
[TBL] [Abstract][Full Text] [Related]
31. MYC-induced reprogramming of glutamine catabolism supports optimal virus replication.
Thai M; Thaker SK; Feng J; Du Y; Hu H; Ting Wu T; Graeber TG; Braas D; Christofk HR
Nat Commun; 2015 Nov; 6():8873. PubMed ID: 26561297
[TBL] [Abstract][Full Text] [Related]
32. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
Aoki T; Shimada K; Sakamoto A; Sugimoto K; Morishita T; Kojima Y; Shimada S; Kato S; Iriyama C; Kuno S; Harada Y; Tomita A; Hayakawa F; Kiyoi H
Oncotarget; 2017 Feb; 8(8):13085-13098. PubMed ID: 28055963
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation.
Bott AJ; Peng IC; Fan Y; Faubert B; Zhao L; Li J; Neidler S; Sun Y; Jaber N; Krokowski D; Lu W; Pan JA; Powers S; Rabinowitz J; Hatzoglou M; Murphy DJ; Jones R; Wu S; Girnun G; Zong WX
Cell Metab; 2015 Dec; 22(6):1068-77. PubMed ID: 26603296
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.
Lustig LC; Dingar D; Tu WB; Lourenco C; Kalkat M; Inamoto I; Ponzielli R; Chan WCW; Shin JA; Penn LZ
Oncogene; 2017 Dec; 36(49):6830-6837. PubMed ID: 28806396
[TBL] [Abstract][Full Text] [Related]
35. c-myc oncogene expression and cell proliferation in mixed oligo-astrocytoma.
Banerjee M; Dinda AK; Sinha S; Sarkar C; Mathur M
Int J Cancer; 1996 Mar; 65(6):730-3. PubMed ID: 8631582
[TBL] [Abstract][Full Text] [Related]
36. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
[TBL] [Abstract][Full Text] [Related]
37. Glutamine Addiction In Gliomas.
Márquez J; Alonso FJ; Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA
Neurochem Res; 2017 Jun; 42(6):1735-1746. PubMed ID: 28281102
[TBL] [Abstract][Full Text] [Related]
38. [Observations on expression of c-fos and c-myc genes and activity of PDGFBB autocrine loop in 67 human gliomas].
Yu S; Pu P; Jiang D; Cheng Y; An T; Guan X
Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):182-6. PubMed ID: 11869525
[TBL] [Abstract][Full Text] [Related]
39. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.
Pajovic S; Siddaway R; Bridge T; Sheth J; Rakopoulos P; Kim B; Ryall S; Agnihotri S; Phillips L; Yu M; Li C; Milos S; Patel P; Srikanthan D; Huang A; Hawkins C
Nat Commun; 2020 Dec; 11(1):6216. PubMed ID: 33277484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
